Pacific Growth Equities

FREMONT, Calif.--(BUSINESS WIRE)-- ARYx Therapeutics, Inc. (NASDAQ: ARYX) today announced that it has entered into a securities purchase agreement in connection with a private placement to a group of accredited investors led by new investor New Enterprise Associates (NEA) with participation from significant existing shareholders including MPM Capital and OrbiMed Advisors LLC. Pursuant to the terms of the securities purchase agreement, ARYx will receive approximately $21.6 million in gross proceeds from the sale of 9,649,545 shares of its common stock and the issuance of warrants for the purchase of 2,894,864 additional shares of ARYx's common stock with an exercise price of $2.64 per share and having a term of five (5) years from the closing date. The combined purchase price of a share of ARYx's common stock and ...

WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) today announced that 28 renowned clinicians and investigators will be featured in Therapeutic Workshops(TM) at the Seventh Annual BIO Investor Forum on October 29-31 at the Palace Hotel in San Francisco, Calif. A distinguished panel of industry leaders hand-selected these experts to discuss biotechnology pipeline innovation and the latest in clinical strategy. The clinicians and investigators represent prestigious academic institutions and medical foundations. In addition, heads of clinical development from leading public and private biotechnology companies will participate on these panels. "This is the first year in which the BIO Investor Forum, together with Gerson Lehrman Group, has made a robust investment in inviting clinical thought leaders knowledgeable about the biotech and pharmaceutical industries to speak directly to investors," said Jim Greenwood, president and CEO of BIO. "BIO is committed to providing high-quality and independent forums where clinicians and industry leaders can drive insightful discussion on innovative clinical-stage products pioneered ...

SEATTLE--(BUSINESS WIRE)-- The Washington Biotechnology & Biomedical Association (WBBA) will host its annual life sciences investment conference, Invest Northwest(TM), on March 17-18, 2009, at Bell Harbor International Conference Center in Seattle. Registration is now open. To register, visit www.washbio.org. Click "Invest Northwest" to begin. See registration for pricing. Organizers of Invest Northwest 2009 continue to assemble event programming. Presenting companies will be announced this Winter. ...

WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) today announces plenary sessions and roundtables planned for the Seventh Annual BIO Investor Forum that address how small biotech companies can continue to innovate and grow despite current market conditions. "Each session focuses on novel ways to navigate today's challenging economic landscape," said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO. "We have brought together the best minds in the industry to share creative and non-traditional approaches to business models, financing, and partnership deals that will help to insulate companies from these challenges." The BIO Investor Forum's plenary sessions and business roundtables will focus on economic and business issues facing the biotech industry, including M&A, capital access, exit strategies, technology transfer, and ...

PITTSBURGH--(BUSINESS WIRE)-- PPG Industries (NYSE: PPG) has acquired the automotive refinish coatings business of the Bonny Coating-Made Co., Ltd. (Bonny), in Guangzhou, China. The business will operate as an indirect subsidiary of PPG. Financial terms were not disclosed. The assets to ...